4 reports

  • CHAPTER III LUNG CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS
  • Lung Cancer Treatment Drugs Production and Demand

It is one major anti-cancers producer in China.

  • Cancer
  • Healthcare
  • Lung Cancer
  • Pharmaceutical
  • Yangtze River Pharmaceutical Group Co., Ltd.
  • CHAPTER III LUNG CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS
  • Major Producer Facility Locations and Output

It is one major anti-cancers producer in China.

  • Cancer
  • Lung Cancer
  • Pharmaceutical
  • Yangtze River Pharmaceutical Group Co., Ltd.
  • Zhejiang Expressway Co., Ltd.
  • PRODUCTS UNDER DEVELOPMENT BY COMPANIES, H1 2018
  • Toll Like Receptor 8 (CD288 or TLR8) - Therapeutics Development

In this trial, ## patients with PASI scores of ##. ## or greater will be randomized ##:##:##:## to receive weekly subcutaneous doses of IMO-## at ##. ##, ##. ##, or ##. ## mg/ kg/ week or placebo for ## weeks.

  • Cancer
  • Lymphoma
  • Pharmaceutical
  • Therapy
  • Idera Pharmaceuticals, Inc.
  • Toll Like Receptor 8 (CD288 or TLR8) - Therapeutics Development
  • Toll Like Receptor 8 (CD288 or TLR8) - Dormant Products

In this trial, ## patients with PASI scores of ##. ## or greater will be randomized ##:##:##:## to receive weekly subcutaneous doses of IMO-## at ##. ##, ##. ##, or ##. ## mg/ kg/ week or placebo for ## weeks.

  • Cancer
  • Lymphoma
  • Pharmaceutical
  • Therapy
  • Idera Pharmaceuticals, Inc.